{
    "clinical_study": {
        "@rank": "63835", 
        "arm_group": [
            {
                "arm_group_label": "Sufficeint", 
                "arm_group_type": "No Intervention", 
                "description": "In this arm the participants have a Vitamin D level of greater than 75 ng/ml. They will continue to be monitored throughout the study but will not receive any intervention."
            }, 
            {
                "arm_group_label": "Mild Insufficiency", 
                "arm_group_type": "No Intervention", 
                "description": "In this arm the participants have a Vitamin D level between 37.5 - 75 ng/ml. The participants will be monitored throughout the study but will receive no intervention."
            }, 
            {
                "arm_group_label": "Severe Deficiency no treatment", 
                "arm_group_type": "No Intervention", 
                "description": "In this arm the participants have a low Vitamin D level of less than 37.5 ng/ml. The participants will be monitored but will receive no intervention."
            }, 
            {
                "arm_group_label": "Severe Deficiency - Treatment", 
                "arm_group_type": "Experimental", 
                "description": "In this arm the participants will be treated with Vitamin D. The participants will be prescribed a dose of 1000 IU a day (1 pill a day). At 6 weeks the dosage will increase to 2000 IU a day (2 pills a day)."
            }
        ], 
        "brief_summary": {
            "textblock": "Patients will undergo at baseline and regular intervals:\n\n        -  clinically indicated bloodwork/urine and echocardiogram testing\n\n        -  biomarker studies\n\n      Upon enrolment in the study patients will be divided into 4 groups normal, mildly deficient\n      and severely deficient. Normal and mild vitamin D levels will receive no treatment while\n      severe Vitamin D deficiency will be randomized (50/50) to receive no treatment or vitamin D\n      treatment. They will be seen in the heart failure clinic every 6 months. The patients will\n      be followed for 26 months."
        }, 
        "brief_title": "The Role of Vitamin D in the Pathophysiology of Chronic Failure", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Vitamin D Deficiency", 
            "Chronic Heart Failure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Heart Failure", 
                "Vitamin D Deficiency"
            ]
        }, 
        "detailed_description": {
            "textblock": "The inclusion criteria for the study is:\n\n        -  an EF \u226440% within the last 12 months before recruitment\n\n        -  established diagnosis of heart failure\n\n        -  >18 years of age\n\n        -  patients will vitamin d levels of sufficient, mild deficiency and severe deficiency\n\n      The exclusion criteria is:\n\n        -  hypercalcemia\n\n        -  known hypersensitivity to Vitamin D\n\n        -  patient unwilling to comply with study requirements\n\n        -  any other disease other than heart failure that can alter the patients quality of life\n           over a period of 6 months\n\n        -  women of child bearing potential\n\n        -  a patient currently taking vitamin d\n\n        -  severe renal impairment estimated glomerular filtration rate (eGFR) <30"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  an ejection fraction (EF) \u226440% within the last 12 months before recruitment\n\n          -  established diagnosis of heart failure\n\n          -  >18 years of age\n\n          -  patients with Vitamin D levels of sufficient, mild deficiency and severe deficiency\n\n        Exclusion Criteria:\n\n          -  hypercalcemia\n\n          -  known hypersensitivity to Vitamin D\n\n          -  patient unwilling to comply with study requirements\n\n          -  any other disease other than heart failure that can alter the patients quality of\n             life over a period of 6 months\n\n          -  women of child bearing potential\n\n          -  a patient currently taking vitamin d\n\n          -  severe renal impairment eGFR <30"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01993537", 
            "org_study_id": "20120585"
        }, 
        "intervention": {
            "arm_group_label": "Severe Deficiency - Treatment", 
            "intervention_name": "Vitamin D", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 18, 2013", 
        "location": {
            "contact": {
                "email": "jdonaldson@ottawaheart.ca", 
                "last_name": "JoAnn Donaldson", 
                "phone": "613-761-4296"
            }, 
            "contact_backup": {
                "email": "abaker@ottawaheart.ca", 
                "last_name": "Ann Baker", 
                "phone": "613-761-5120"
            }, 
            "facility": {
                "address": {
                    "city": "Ottawa", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "K1Y 4W7"
                }, 
                "name": "The University of Ottawa Heart Institute"
            }, 
            "investigator": [
                {
                    "last_name": "Haissam Haddad", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Girish Dwivedi", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Ali Pourdjabbar", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Lisa Mielniczuk", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Ian Burwash", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "marcel Ruzicka", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "4", 
        "official_title": "The Role of Vitamin D in the Pathophysiology of Chronic Failure: Insight in to Mechanisms of Action and Implications for Vitamin D Supplementation", 
        "overall_contact": {
            "email": "jdonaldson@ottawaheart.ca", 
            "last_name": "JoAnn Donaldson", 
            "phone": "613-761-4296"
        }, 
        "overall_contact_backup": {
            "email": "abaker@ottawaheart.ca", 
            "last_name": "Ann Baker", 
            "phone": "613-761-5120"
        }, 
        "overall_official": {
            "affiliation": "The University of Ottawa Heart Insitute", 
            "last_name": "Haissam Haddad", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome for the study is to identify the prevalence of Vitamin D deficiency amongst chronic heart failure patients followed at the University of Ottawa Heart Institute. This will be done analyzing the Vitamin D blood levels at baseline.", 
            "measure": "prevalence of Vitamin D deficiency  amongst chronic heart failure patients at the University of Ottawa Heart Institute", 
            "safety_issue": "No", 
            "time_frame": "up to 3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01993537"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Ottawa Heart Institute", 
            "investigator_full_name": "Haissam Haddad", 
            "investigator_title": "Director Heart Failure Program, Medical Director Heart Transplant Program", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "clinical endpoints of: hospitalizations for worsening congestive heart failure, death will be compared for severe Vitamin D deficient patients receiving Vitamin D supplementation vs severe Vitamin D deficient patients receiving no intervention", 
            "measure": "To demonstrate that Vitamin D deficiency is associated with poor outcome and that Vitamin D supplementation can be of clinical benefit", 
            "safety_issue": "No", 
            "time_frame": "up to 3 years"
        }, 
        "source": "University of Ottawa Heart Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Ottawa Heart Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}